Cargando…
Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis
BACKGROUND: Prior to clinical trials of new TB drugs or therapeutic vaccines, it is necessary to develop monitoring tools to predict treatment outcomes in TB patients. Urine interferon gamma inducible protein 10 (IP-10) is a potential biomarker of treatment response in chronic hepatitis C virus infe...
Autores principales: | Kim, Song Yee, Kim, Jungho, Kim, Deok Ryun, Kang, Young Ae, Bong, Sungyoung, Lee, Jonghee, Kim, Suyeon, Lee, Nam Suk, Sim, Bora, Cho, Sang-Nae, Kim, Young Sam, Lee, Hyejon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975508/ https://www.ncbi.nlm.nih.gov/pubmed/29843631 http://dx.doi.org/10.1186/s12879-018-3144-3 |
Ejemplares similares
-
Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach
por: Cho, Yonggeun, et al.
Publicado: (2020) -
In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection
por: Lee, Hyejon, et al.
Publicado: (2019) -
Identification of MicroRNAs as Potential Blood-Based Biomarkers for Diagnosis and Therapeutic Monitoring of Active Tuberculosis
por: Kim, Junseong, et al.
Publicado: (2022) -
Predictors for False-Negative Interferon-Gamma Release Assay Results in Hemodialysis Patients with Latent Tuberculosis Infection
por: Park, Heechul, et al.
Publicado: (2022) -
Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy
por: Leem, Ah Young, et al.
Publicado: (2018)